US$ 21.15
oral glutathione melasma randomized trial Efficacy of an Supplement on Dark Spot Pigmentation in Healthy Caucasian Subjects: a Double Blind, Placebo-Controlled Clinical Study[v1] Randomized and controlled trials, prospective
Description
A 2010 study by Tudor and colleagues in Regulatory Peptides reported that BPC-157 at 10 g/kg or 10 ng/kg i.p., given 30 minutes before falling-weight traumatic brain injury in mice, directionally reduced unconsciousness and mortality across force impulses of 0.0680.145 Ns, with the higher dose effective at the maximum 0.159 Ns impulse though the abstract does not report numeric mortality percentages or p-values
![oral glutathione melasma randomized trial Efficacy of an Supplement on Dark Spot Pigmentation in Healthy Caucasian Subjects: a Double Blind, Placebo-Controlled Clinical Study[v1] Randomized and controlled trials, prospective](https://www.researchgate.net/publication/362353822/figure/tbl1/AS:1183617376104448@1659207781360/Randomized-and-controlled-trials-prospective-and-comparative-studies-about-chemical.png)
Read More Key Benefits Assists in reducing dark spots and pigmentation with ingredients like Pomegranate and Mulethi
![oral glutathione melasma randomized trial Efficacy of an Supplement on Dark Spot Pigmentation in Healthy Caucasian Subjects: a Double Blind, Placebo-Controlled Clinical Study[v1] Randomized and controlled trials, prospective](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a0/9464276/3cfc363355cf/13555_2022_780_Fig1_HTML.jpg)
Whether sperm deoxyribonucleic acid fragmentation has an effect on pregnancy and miscarriage after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis
![oral glutathione melasma randomized trial Efficacy of an Supplement on Dark Spot Pigmentation in Healthy Caucasian Subjects: a Double Blind, Placebo-Controlled Clinical Study[v1] Randomized and controlled trials, prospective](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-025-10129-4/MediaObjects/41598_2025_10129_Fig1_HTML.png)
The MPIB NGS Core Facility (RRID:SCR_025746), MPIB Mass Spectrometry Facility (RRID:SCR_025745) and MPIB Bioinformatics Core Facility (RRID: SCR_025742) were used for this project
![oral glutathione melasma randomized trial Efficacy of an Supplement on Dark Spot Pigmentation in Healthy Caucasian Subjects: a Double Blind, Placebo-Controlled Clinical Study[v1] Randomized and controlled trials, prospective](https://figures.semanticscholar.org/83ea9a78414f20b1af8b6de501f6baa92c1cacae/3-Table3-1.png)